As per the attachment
STALLION · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Stallion India Fluorochemicals reported strong FY26 results with Total Revenue of ₹434.12 crores (up 14.40% YoY), EBITDA of ₹61.35 crores (up 23.34%), and PAT of ₹43.84 crores (up 35.61%). EPS improved to ₹5.34 from ₹4.38. The company successfully navigated global energy volatility and supply-chain disruptions through proactive sourcing and inventory planning. A key growth driver is the proposed 10,000 MT R-32 manufacturing facility at Bhilwara, Rajasthan, which has received Environmental Clearance and remains on track for commencement by October 2026. Management is targeting a revenue CAGR of 30-35% over the next 3 years while improving margins by 3-4%.
Strong profitability growth with PAT up 35.61% signals operational efficiency gains. The forward guidance of 30-35% revenue CAGR and margin improvement targets, along with the R-32 facility approval, indicate positive long-term prospects for shareholders.